AKYA Akoya Biosciences, Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research. The company offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. It provides two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational, and clinical research. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

$12.08  -0.53 (-4.20%)
As of 12/03/2021 11:12:18 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Medical Instruments & Supplies
Index country:  USA
Country of incorporation:  USA
IPO date:  04/16/2021
Outstanding shares:  37,207,823
Average volume:  212,086
Market cap:   $488,910,794
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    00974H104
ISIN:        US00974H1041
Sedol:      BM9FJ35
Valuation   (See tab for details)
PE ratio:   -17.19
PB ratio:   3.41
PS ratio:   9.46
Return on equity:   -22.53%
Net income %:   -59.91%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy